Literature DB >> 3147804

Prostaglandins involved in contractions by angiotensin II and bradykinin of isolated dog sphincter pupillae.

W Lu1, T Okamura, K Bian, A Inatomi, N Toda.   

Abstract

1. The dog isolated sphincter pupillae contracted in response to acetylcholine, angiotensin II (AII), bradykinin, prostaglandins F2 alpha, D2, E2 and I2, and thionate thromboxane A2 (sTXA2) in a concentration-dependent manner. 2. AII-induced contractions were suppressed by treatment with saralasin, indomethacin, aspirin and diphloretin phosphate (DPP), a prostaglandin receptor antagonist. Contractions induced by bradykinin were also attenuated by indomethacin, aspirin and DPP. The amount of prostaglandin F2 alpha (PGF2 alpha) in the bathing media was increased approximately 41% following stimulation of the preparations by bradykinin. 3. The potency of contractile responses was in the order of PGF2 alpha greater than PGD2 = sTXA2 greater than PGE2 greater than arachidonic acid greater than PGI2. Contractions induced by PGF2 alpha were not significantly affected by treatment with indomethacin and ONO3708, an antagonist of the vasoconstrictor effect of prostaglandins, but appreciably attenuated by DPP. Arachidonic acid-induced contractions were inhibited by indomethacin. 4. Contractions of dog iris sphincter muscle in response to AII and bradykinin may be mediated via substances synthesized by cyclo-oxygenase from arachidonic acid. The distribution and nature of the prostaglandin receptors appear to differ markedly in iris sphincter and vascular smooth muscles.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147804      PMCID: PMC1854177          DOI: 10.1111/j.1476-5381.1988.tb11675.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Interactions of thromboxane A2 analogs and prostaglandins in isolated dog arteries.

Authors:  N Toda; M Nakajima; T Okamura; M Miyazaki
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.105

2.  Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.

Authors:  J W Aiken; J R Vane
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

3.  Relative potency of cholinomimetic drugs on the bovine iris sphincter strips.

Authors:  D N Yamauchi; L DeSantis; P N Patil
Journal:  Invest Ophthalmol       Date:  1973-01

4.  Elevation of cytoplasmic free calcium concentration by stable thromboxane A2 analogue in human platelets.

Authors:  Y Kawahara; J Yamanishi; Y Furuta; K Kaibuchi; Y Takai; H Fukuzaki
Journal:  Biochem Biophys Res Commun       Date:  1983-12-28       Impact factor: 3.575

5.  Prostaglandin antagonism by polymeric phosphates of phloretin and related compounds.

Authors:  K Eakins
Journal:  Ann N Y Acad Sci       Date:  1971-04-30       Impact factor: 5.691

6.  Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.

Authors:  N Toda
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

7.  Heterogeneity in mechanisms of bradykinin action in canine isolated blood vessels.

Authors:  N Toda; K Bian; T Akiba; T Okamura
Journal:  Eur J Pharmacol       Date:  1987-03-31       Impact factor: 4.432

8.  The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin.

Authors:  U Förstermann; G Hertting; B Neufang
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

9.  The effects of prostaglandins on the intraocular pressure of the rabbit.

Authors:  B R Beitch; K E Eakins
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

10.  Evidence for a prostacyclin-mediated chronotropic effect of angiotensin II in the isolated cat right atria.

Authors:  R K Türker
Journal:  Eur J Pharmacol       Date:  1982-09-24       Impact factor: 4.432

View more
  2 in total

1.  Mechanism of irritant-induced cough: studies with a kinin antagonist and a kallikrein inhibitor.

Authors:  R L Featherstone; J E Parry; D M Evans; D M Jones; H Olsson; M Szelke; M K Church
Journal:  Lung       Date:  1996       Impact factor: 2.584

2.  The renin-angiotensin system in the human eye.

Authors:  N J Van Haeringen
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.